Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-202.02%Free Cash Flow Yield
VS
Market
Sector
Industry
History
$ 0.68Close
$ 0.58 - $ 3.8 52-Week Range
Ticker Information
Ticker
GTBPCompany Name
GT BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGT BIOPHARMA INC - Free Cash Flow Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GTBP - FCF Yield Historical data
| Date | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
|---|---|---|---|
| 6/30/2025 | $ -10.42M | -202.02% | $ 5.16M |
| 3/31/2025 | $ -10.94M | -188.88% | $ 5.79M |
| 12/31/2024 | $ -12.9M | -268.62% | $ 4.8M |
| 9/30/2024 | $ -12.48M | -185.61% | $ 6.73M |
| 6/30/2024 | $ -11.71M | -228.86% | $ 5.12M |
| 3/31/2024 | $ -10.11M | -233.96% | $ 4.32M |
| 12/31/2023 | $ -8.85M | -145.72% | $ 6.07M |
| 9/30/2023 | $ -11.1M | -107.23% | $ 10.35M |
| 6/30/2023 | $ -12.06M | -105.96% | $ 11.38M |
| 3/31/2023 | $ -12.91M | -115.01% | $ 11.22M |
Key Performance Insights, Last 5 Years
- GT BIOPHARMA INC's latest trailing twelve months (TTM) FCF Yield stands at -40.63%.
- Over the past 5 years, GT BIOPHARMA INC's average FCF Yield has been -100.89%.
- The median FCF Yield for GT BIOPHARMA INC during this period was -97.45%
- GT BIOPHARMA INC reached its highest FCF Yield over the past 5 years at -2.6%.
- The lowest FCF Yield recorded by GT BIOPHARMA INC in the same timeframe -268.62%
Similar metrics to Market Cap:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
Definition of Free Cash Flow Yield
[Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.FCF / Market Cap
(=) FCF Yield FCF Yield for GT BIOPHARMA INC is calculated as follows: FCF [ $ -5.82M ] / Market Cap [ $ 14.32M ]
(=) FCF Yield [ -40.63% ] GTBP - Free Cash Flow Yield, Last 5 years
-268.62%
Minimum
Dec 31, 2024
-2.6%
Maximum
Dec 31, 2020
-100.89%
Average
-97.45%
Median
FCF Yield Benchmark AnalysisMarket
The chart above depicts the distribution of FCF Yield for companies in the Total Stock Market. The average FCF Yield of the companies is 1.62% with a standard deviation of 11.36%.
The following table provides additional summary stats:
FCF Yield in the Market:
| filtered constituents | 3.58K |
|---|---|
| min | -33.87% |
| max | 37.55% |
| average | 1.62% |
| median | 3.25% |
| std | 11.36% |